Micromedic Technologies Ltd. specializes in the development and commercialization of novel and innovative cancer diagnostic products. Our portfolio spans a wide range of cancer and cancer-related indications including colorectal cancer, breast cancer, cervical cancer, bladder cancer, lung cancer, and diagnostic tools for personalized treatment.
Micromedic is a public company traded on the Tel Aviv Stock Exchange (TASE: MCTC).
